Tue, May 4, 2021
Mon, May 3, 2021
Fri, April 30, 2021
Thu, April 29, 2021

John Newman Maintained (AGIO) at Strong Buy with Increased Target to $65 on, Apr 30th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-65-on-apr-30th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

John Newman of Canaccord Genuity, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Increased Target from $57 to $65 on, Apr 30th, 2021.

John has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, all agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Held Target at $54 on, Monday, March 1st, 2021
  • Andrew Berens of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $50 on, Friday, February 26th, 2021

Publication Contributing Sources